American Conference
Institute (ACI) will be holding its Hatch-Waxman Boot Camp conference on July
19-20, 2010 in Boston, MA.  ACI
faculty will help attendees:

• Understand the
interplay of the PTO and FDA in the patenting of drugs and biologics;
• Learn about the
essentials of the FDA approval process and its link to biopharmaceutical
patents;
• Develop an
in-depth and practical knowledge of Hatch-Waxman protocols, including: Orange
Book listings, bioequivalency, exclusivities, the 30-month stay, and the safe
harbor;
• Navigate the
intricacies of patent term adjustment and patent term restoration;
• Comprehend how
the introduction of biosimilars will change industry dynamics; and
• Recognize how
pre-commercialization concerns relative to CMS approval and Medicare/Medicaid
formulary selection are influencing the patenting and approval of drugs and
biological products.

In particular,
ACI's faculty will offer presentations on the following topics:

• Key agencies
overview:  Understanding the
jurisdiction and interplay of the FDA and PTO in the patenting of drugs and
biologics;
• Identifying and
comprehending pre-commercialization concerns relative to small molecules and
biologics;
• Exploring the
link between the FDA approval process and the patenting of drugs and biologics;
• Patent and IP
overview for drugs and biologics: 
Hatch-Waxman, trade dress, and more;
• How the dynamics
of follow-on biologics will change the Hatch-Waxman landscape;
• Orange Book
listings, de–listings, and related challenges;
• Bioequivalence
and the "same active ingredient" vis-a-vis patentability;
• A in-depth look
at 180-day exclusivity;
• Comprehending the
intricacies of non-patent/regulatory exclusivity;
• Assessing patent
protections afforded under the safe harbor; and
• Examining
pharmaceutical patent extensions: 
Patent Term Adjustment and Patent Term Restoration.

Two post-conference
workshops will be offered on July 21, 2010.  The first, entitled "Follow–On Biologics: The Master
Class," will be offered from 9:00 am to 12:00 pm, and will take attendees
through every facet of this exciting and challenging new area.  The second workshop, entitled
"Practical Considerations Surrounding Pre-Lawsuit Paragraph IV Diligence
from Both a Brand and Generic Perspective," will delve into the practical
side of the A to Z pre-lawsuit diligence necessary leading up to and including
filing of the Paragraph IV lawsuit including, obviousness and non-obviousness
searching, notice Letter preparation, brand response, offers of confidentiality,
and venue.

A complete brochure
for this conference, including an agenda, list of speakers, and registration
form can be obtained here.

The registration
fee for this conference is $2,195 (conference alone), $2,795 (conference and
one workshop), or $3,195 (conference and two workshops).  Those registering by June 11, 2010 will
receive a $200 discount.  Those
interested in registering for the conference can do so here,
by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.

Patent Docs is a media partner of ACI's Hatch-Waxman Boot Camp conference.

Practising
Law Institute (PLI) will be holding a seminar entitled: "Markman Hearings and Claim Construction
in Patent Litigation 2010" on June 30, 2009 in New York, NY.  Groupcasts of the New York session will
also be held in Atlanta, GA; Mechanicsburg, PA; Philadelphia, PA; and
Pittsburgh, PA.  The seminar will provide information on the
following topics:

•
Overview of Markman and its progeny;
the promises and the realities of Markman
in practice;
•
Claim construction procedure, strategies, and tactics;
•
How to prepare and prosecute patent applications to obtain appropriate claim
construction;
•
Discovery, timing, alternatives, and challenges in multi-patent and multi-party
cases;
•
Special claim construction problems;
•
Use of experts, inventors, and masters;
•
Claim construction from an appellate perspective; and
•
After the Markman hearing — effect
on further trial proceedings.

In particular,
PLI's faculty will offer presentations on the following topics:

1.  Markman
law and claim construction procedures in litigation;
    a.  Overview of Markman and its progeny; the promises and the realities of Markman in practice;
    b.  Claim construction strategy and tactics
in litigation;
2.  How to present an effective Markman hearing;
    a.  The Markman
hearing itself — Practical tips and strategies;
    b.  Special claim construction problems;
3.  Claim construction from business and
governmental perspectives;
    a.  Business perspective;
    b.  Government perspective;
4.  Markman
hearing presentation;
    a.  Patentee's presentation;
    b.
Accused infringer's presentation;
    c.
Discussion of Markman presentations;
5.  Markman judges'
panel:  A symposium on the
practice, procedure and perspectives of the judiciary and on bigger Markman issues.

A
program schedule and list of speakers for the seminar can be found here.  The registration fee for the conference
is $1,495.  Those interested in
registering for the New York seminar can do so here; those interested in
registering for the Groupcasts can do so here (Atlanta), here (Mechanicsburg),
here (Philadelphia) or here (Pittsburgh).

Practising
Law Institute (PLI) will be holding a seminar entitled: "Prior Art &
Obviousness 2010:  Current Trends
in Sections 102 & 103" on July 7, 2010 in New York, NY and on
September 15, 2010 in San Francisco, CA. 
The seminar will
provide information on the following topics:

•
When is a patent a "patent" under the statute?
•
Public accessibility — on the web, on the shelf, in the mail,
"routine" practices;
•
Four steps to the abyss of 102(d);
•
Ex parte 102(g); abandon, suppress, conceal;
•
Actual vs. constructive reduction to practice (where 102(e) trumps 102(g));
•
What have they done to 102(e)?
•
The issues raised by successive common owner filings;
•
A walk through the "guidelines" and "timelines"; and
•
Impact of proper/improper benefit claims on:  a) prior art date of a reference, and b) effective filing
date of the application being examined.

In particular,
PLI's faculty will offer presentations on the following topics:

I. 
Section 102 and the MPEP, from (a) to (g) (or what isn't in the statute but is
in the law?);
II. 
Section 103 and the PTO KSR
guidelines;
III. 
Section 102(a) – (d);
    A.  102(a) & (b) and the CAFC 2008;
    B.  102(c) & (d):  Abandonment and the "four
steps";
IV.  102(f) & (g):  Joint ventures and co-development;
V.  35 U.S.C. 103 and the CAFC; and
VI.  102(e) and the 9 most common
timelines:  Effects of priority
under 119, 120, 121, 365.

A
program schedule and list of speakers for the New York Patent Law Institute can
be found here, and a
program schedule and list of speakers for the San Franscisco Patent Law
Institute can be found here.

The
registration fee for the conference is $1,495.  Those interested in registering for the conference can do so
here (New York) or here (San Francisco).

The
Analysis Group, Georgetown University's Center for Business and Public Policy,
and McKool Smith will be offering a seminar entitled "Patent Reform 2010:
What Shape Will It Finally Take?" on June 15, 2010 from 8:00 – 11:30
AM (EST) in Washington, DC.  A panel of experts from
industry, law, and politics will discuss the need for patent reform and the
current legislative landscape, the pros and cons of bills under consideration,
and the future implications for research, licensing, and litigation.  Panelists will include Federal Circuit
Chief Judge Paul Michel (retiring); Representative Dana Rohrabacher (R-CA); Joe
Matal, Republican General Counsel for the Senate Judiciary Committee; Cheryl
Miller, Deputy Staff Director for Technology and Innovation for the Senate
Committee on Small Business and
Entrepreneurship; Philip Johnson, Chief
Intellectual Property Counsel for Johnson & Johnson; Bernard Cassidy,
Executive Vice President and General Counsel for Tessera Technologies; Hans
Sauer, Deputy General Counsel for Intellectual Property of the Biotechnology
Industry Organization (BIO); Jonathan Dudas, Partner at Foley & Lardner;
Douglas Cawley, Principal at McKool Smith; Brian Riopelle, Partner at
McGuireWoods; Pat Choate, Economist and Author; John Jarosz, Managing Principal
for the Analysis Group; and Professor John Mayo, Georgetown University.

Those
interested in registering for the seminar, can do so here.

The
American Bar Association (ABA) Center for Continuing Legal Education and ABA
Section of Science & Technology Law will be offering a teleconference and
live audio webcast entitled "Navigating the U.S. Biosimilar Pathway"
on June 29, 2010 from 1:00 – 2:30 PM (EST).  Dr. William Simmons of Sughrue Mion, PLLC; Kenneth Burchfiel
of Sughrue Mion, PLLC; Krista Hessler Carver of Covington & Burling LLP;
and Michael Dzwonczyk of Sughrue Mion, PLLC will explore the new U.S.
biosimilars pathway, including risks confronting biosimilar producers.

The
registration fee for the webcast is $85 for Section of Science & Technology
Law members, $150 for ABA members, and $185 for the general public (for
additional fee options, please visit the event website).  Those interested in registering for the
webcast, can do so here.

The
American Bar Association (ABA) Center for Continuing Legal Education and ABA
Section of International Law will be offering a teleconference and live audio
webcast entitled "Regulatory and Intellectual Property Opportunities and
Challenges for Life Science Companies Entering the U.S. Market" on June
23, 2010 from 12:00 – 1:30 PM (EST).  Dr. MaryAnne Armstrong of Birch, Stewart, Kolasch and Birch,
LLP; Alan Minsk of Arnall Golden Gregory LLP; and Dr. Steven K. Stranne of
Polsinelli Shughart PC will discuss potential opportunities and challenges and
offer recommendations to protect company interests and maximize product
benefits for life sciences companies, particularly early-stage companies.  The panel will focus on patent
considerations, regulatory issues with the Food and Drug Administration, and
reimbursement strategies focusing primarily on medical devices.

The
registration fee for the webcast is $85 for Section of International Law
members, $125 for ABA members, and $150 for the general public (for additional
fee options, please visit the event website).  Those interested in registering for the webcast, can do so
here.